You are here: Industry Insights > Biologics

News List

CDMO Stelis Continues Expansion contractpharma
December 02, 2020
Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd., has started the next phase of its continued investment program after having already invested well over $100 million into its ...
Cue Biopharma, Merck Extend Biologics Research Alliance contractpharma
November 20, 2020
To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.
Microbial contract biomanufacturing market to be worth $9.3 billion by 2030 europeanpharmaceuticalreview
November 18, 2020
A new analysis suggests that Europe and North America will capture more than 80 percent of the $9.3 billion market by 2030.
PathoQuest, Charles River Expand Strategic Pact contractpharma
November 13, 2020
Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.
Thermo Fisher Scientific, Innoforce to set up biologics and steriles drug manufacturing facility in China expresspharma
November 09, 2020
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing.
Stevanato Group, Catalent Partner to Expedite Equipment Installation contractpharma
October 29, 2020
Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.
Bioanalytical testing services market to become a $4.5 billion industry europeanpharmaceuticalreview
October 21, 2020
A report found the rise in outsourcing, growing popularity of biologics and expanding acceptance of quality-by-design approaches would drive the market expansion.
Almac Launches Biologics Testing Services contractpharma
September 27, 2020
New services include GMP lot release and stability testing to support drug substance and drug product programs for biologics and biosimilars.
Catalent Acquires New Biologics Facility contractpharma
September 27, 2020
Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has acquired a new manufacturing facility in Bloomington, IN ...
Aphena Pharma Invests $21M in Tennessee Expansion contractpharma
September 23, 2020
Adds 258,000 sq.-ft. to current Cookeville footprint and represents expansion into biologics, cold chain storage and third-party logistics distribution.

Previous page 1 2 3 4 5 6 7 8 9 Next page